Ledger.Open graph →
SEC Form D · filed April 8, 2011

Akebia Therapeutics, Inc

Offering
$19.0M
Sold
$12.0M
Exemption
Industry
Biotechnology
Location
CINCINNATI, OH
Type

People & firms on this filing (16)

Campbell Murray · Cincinnati, OHDirectorJoseph Gardner · Cincinnati, OHExec · DirectorAnupam Dalal · Cincinnati, OHDirectorIan Howes · Cincinnati, OHExecJohn Rice · Cincinnati, OHDirectorRobert Shalwitz · Cincinnati, OHExecKevin Peters · Cincinnati, OHExecPaul Weiss · Cincinnati, OHDirectorMichael W. Perry · Portland, ORDirectorJames G. Baughman · DENVER, CODirectorMark E. Scott · DENVER, CODirectorDouglas E. Hailey · NEW YORK, NYDirectorRichard L. Baum · NEW YORK, NYExec · DirectorJosh Sugidono · NEW YORK, NYExecScott K. Wolf · NEW YORK, NYExecChris J. Littlefield · NEW YORK, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗